Recurrent miscarriage

Current Women's Health Reports

Volumn 3, Issue 5, 2003, Pages 361-366

  Dhont, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTICOAGULANT AGENT; CAFFEINE; CHORIONIC GONADOTROPIN; CORTICOSTEROID; FOLIC ACID; GONADORELIN DERIVATIVE; HEPARIN; HUMAN MENOPAUSAL GONADOTROPIN; IMMUNOGLOBULIN; INSULIN SENSITIZING AGENT; METFORMIN; PHOSPHOLIPID ANTIBODY; PROGESTERONE; THYROID HORMONE;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; ENDOCRINE SYSTEM; FIRST TRIMESTER PREGNANCY; GENETIC DISORDER; HEREDITY; HUMAN; IMMUNIZATION; INCIDENCE; LOW DRUG DOSE; METABOLISM; OVULATION INDUCTION; PATHOLOGICAL ANATOMY; RECURRENT DISEASE; REVIEW; SPONTANEOUS ABORTION; UTERUS MALFORMATION; UTERUS SURGERY; WEIGHT REDUCTION; ADULT; AUTOIMMUNE DISEASE; ENDOCRINE DISEASE; FEMALE; GENETICS; IMMUNOLOGY; LIFESTYLE; PREGNANCY; RECURRENT ABORTION; RISK FACTOR; WOMEN'S HEALTH;

ABORTION, HABITUAL; ADULT; AUTOIMMUNE DISEASES; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; LIFE STYLE; PREGNANCY; RISK FACTORS; WOMEN'S HEALTH;

EID: 1542568315     PISSN: 15345874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Boué J, Boué A, Lazar P: Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology 1975, 12:11-26.
2. Hassold T, Chen N, Funkhauser J, et al.: A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 1980, 44:151-164.
3. Wilcox AJ, Weinberg CR, O'Conner JF, et al.: Incidence of early loss of pregnancy. N Engl J Med 1988, 319:189-194.
4. Delhanty JD, Harper JC, Ao A, et al.: Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet 1997, 99:755-760.
5. Abdella HI, Burton G, Kirkland A, et al.: Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod 1993, 8:1512-1517.
6. Andersen N, Wohlfahrt J, Christens P, et al.: Maternal age and fetal loss: population based register linkage study. Br Med J 2000, 320:1708-1712.
7. Munné S, Alikani M, Tomkin G, et al.: Embryo morphology, developmental rates and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995, 64:382-391.
8. Regan L, Braude PR, Trembath PL: Influence of postreproductive performance on risk of spontaneous abortion. Br Med J 1989, 299:541-545.
9. Warburton D, Fraser FC: Spontaneous abortion risk in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964, 16:1-25.
10. Poland BJ, Miller JR, Jones DC, Trimble BK: Reproductive counselling in patients who had a spontaneous abortion. Am J Obstet Gynecol 1977, 127:685-691.
11. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR: Spontaneous and recurrent abortion. In Comprehensive Gynecology, edn 4. St. Louis: Mosby; 2001:280-299.
12. Stephenson MD, Awartani KA, Robinson WP: Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case controlled study. Hum Reprod 2002, 17:446-451.
13. Snijders RJ, Sundberg K, Holzgreve W, et al.: Maternal age and gestation-specific risk for trisomy 21: effect of previous affected pregnancy. Ultrasound Obstet Gynecol 1999, 13:167-170.
14. Rubio C, Vidal F, Minguéz Y, et al.: High incidence of chromosomal abnormalities in preimplantation embryos from recurrent spontaneous abortion patients. Hum Reprod 2000, 15:81-82.
15. Lanasa MC, Hogge WA, Kubik CJ, et al.: A novel X chromosome-linked genetic cause of recurrent spontaneous abortion. Am J Obstet Gynecol 2001, 185:563-568.
16. Empson M, Lassere M, Craig JC, Scott JR: Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002, 99:135-144.
17. Management of recurrent early pregnancy loss. American College of Obstetrics and Gynecology Practice Bulletin. 2001, 24:1-17.
18. Ober C, Karrison T, Odem RR, et al.: Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999, 354:365-369.
19. Aldrich CL, Stephenson MD, Karrison T, et al.: HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001, 12:1167-1172.
20. Pfeiffer KA, Fimmers R, Engels G, et al.: The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001, 7:373-378.
21. Branch DW, Porter TF, Paidas MJ, et al.: Obstetric uses of intravenous immunoglobulin: successes, failures, and promises. J Allergy Clin Immunol 2001, 108:S133-S138.
22. Simpson JL, Carson SA, Mills JL, et al.: Prospective study showing that antisperm antibodies are not associated with pregnancy losses. Fertil Steril 1996, 66:36-42.
23. Mills JL, Simpson JL, Driscoll SG, et al.: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988, 319:1617-1623.
24. Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990, 336:1141-1144.
25. Barnes RB: Diagnosis and therapy of hyperandrogenism. Baillieres Clin Obstet Gynaecol 1997, 11:369-396.
26. Hughes E, Collins J, Vandekerckhove P: Gonadotropin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome. Cochrane Database Syst Rev 2000, 2:CD000097.
27. Nardo LG, Rai R, Backos M, et al.: High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 2002, 77:348-352.
28. Rai R, Backos M, Rushworth F, Regan L: Polycystic ovaries and recurrent miscarriage: a reappraisal. Hum Reprod 2000, 15:612-615.
29. Wang JX, Davies MJ, Norman RJ: Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002, 10:551-554.
30. Craig LB, Ke RW, Kutteh WH: Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002, 78:487-490.
31. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al.: Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:524-529.
32. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L: Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002, 17:2858-2864.
33. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand 2003, 82:182-188.
34. Cnattingius S, Signorello LB, Anneren G, et al.: Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med 2000, 343:1839-1845.
35. Leviton A, Cowan L: A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol 2002, 40:1271-1310.
36. Knudsen UB, Hansen V, Juul S, Secher NJ: Prognosis of a new pregnancy following previous spontaneous abortions. Eur J Obstet Gynaecol Reprod Biol 1991, 39:31-36.
37. Stray-Pedersen B, Stray-Pedersen S: Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984, 148:140-146.
38. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Obstet Gynecol 1996, 10:3301-3304.
39. Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-257.
40. Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002, 100:408-413.
41. Vidal F, Rubio C, Simon C, et al.: Is there a place for preimplantation genetic diagnosis screening in recurrent miscarriage patients? J Reprod Fertil Suppl 2000, 55:143-146.